Role of taxane-based chemotherapy drugs may be underestimated, especially against prostate cancer, study suggests

The power of taxane-based chemotherapy drugs are misunderstood and potentially underestimated, according to researchers. Most physicians and investigators believe that taxane chemotherapy (paclitaxel, docetaxel and cabazitaxel) just does one thing — stop a cancer cell from dividing — but the team of scientists has revealed it acts much more powerfully and broadly, especially against prostate …

Posted in Uncategorized